NHS: Drugs
Commons · Question 36735 · Tabled 10 Mar 2025 · Department of Health and Social Care · Official record
Answered 17 Mar 2025
Question
Asked by Preet Kaur Gill
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the role of (a) generic, (b) biosimilar and (c) off-patent medicines in addressing medicine shortages.
Answer
Answered by Karin Smyth, 17 Mar 2025
The resilience of United Kingdom supply chains is a key priority, and the Department is committed to helping to build long term supply chain resilience for medicines. The Department recognises the important role all off patent medicines, including generic...